Back to News
Dec 10, 2025 8:30 AM

Eli Lilly's $6 Billion Alabama Site To Make Next-Gen Weight Loss Pills

Eli Lilly and Co. (NYSE: LLY) on Tuesday today announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama.

The synthetic medicine active pharmaceutical ingredient (API) facility is the third of four new U.S. sites Eli Lilly plans to announce, will produce small molecule synthetic and peptide medicines.

In February, Eli Lilly bolstered its domestic medicine production with total U.S. capital expansion commitments of over $50 billion since 2020.

Also Read: Eli Lilly Eyes India For Manufacturing, Plans To Spend $1 Billion

The company’s previous total domestic capital expansion commitments from 2020 to 2024 totaled $23 billion.

Pipeline Support

The site will ...